Stockreport

Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Sy...

enVVeno Medical Corporation  (NVNO) 
PDF 9.29 Points for Patients at the Two-Year Milestone 8.08 Points for Patients at the One-Year Milestone 8.71 Points for Patients at the Six-Month Milestone 72% of t [Read more]